✦ LIBER ✦

Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease

✍ Scribed by Donato Goffredo; Dorotea Rigamonti; Chiara Zuccato; Marzia Tartari; Marta Valenza; Elena Cattaneo

Book ID: 119346180
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 532 KB
Volume: 52
Category: Article
ISSN: 1043-6618
DOI: 10.1016/j.phrs.2005.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imbalanced Matrix Metalloproteinases in

Imbalanced Matrix Metalloproteinases in Cardiovascular Complications of End-Stage Kidney Disease: A Potential Pharmacological Target

✍ Bernardo P. Marson; Carlos E. Poli de Figueiredo; Jose E. Tanus-Santos 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

Dysfunction of two lysosome degradation

Dysfunction of two lysosome degradation pathways of α-synuclein in Parkinson’s disease: potential therapeutic targets?

✍ Tian-Fang Jiang, Sheng-Di Chen 📂 Article 📅 2012 🏛 Shanghai Institutes for Biological Sciences, Chine 🌐 English ⚖ 396 KB

Genetic and pharmacological targeting of

Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?

✍ Lawrenz, M; Visekruna, A; Kühl, A; Schmidt, N; Kaufmann, S H E; Steinhoff, U 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 657 KB

A novel target for Huntington's disease:

A novel target for Huntington's disease: ERK at the crossroads of signaling : The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology

✍ Bodai, László (author);Marsh, J. Lawrence (author) 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

## Abstract Activating the ERK pathway (extracellular signal‐regulated kinase pathway) has proven beneficial in several models of Huntington's disease (HD), and drugs that are protective in HD models have recently been found to activate ERK. Thus, the ERK cascade may be a potential target for thera

A novel target for Huntington's disease:

A novel target for Huntington's disease: ERK at the crossroads of signaling : The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology

✍ Bodai, László (author);Marsh, J. Lawrence (author) 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

Pharmacologic activation of mitochondria

Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease

✍ Johri, A.; Calingasan, N. Y.; Hennessey, T. M.; Sharma, A.; Yang, L.; Wille, E.; 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 952 KB